BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19585495)

  • 1. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
    Castro FA; Haimila K; Sareneva I; Schmitt M; Lorenzo J; Kunkel N; Kumar R; Försti A; Kjellberg L; Hallmans G; Lehtinen M; Hemminki K; Pawlita M
    Int J Cancer; 2009 Oct; 125(8):1851-8. PubMed ID: 19585495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
    Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
    Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
    J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri.
    Beskow AH; Gyllensten UB
    Int J Cancer; 2002 Oct; 101(6):526-31. PubMed ID: 12237892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.
    Ghaderi M; Nikitina Zake L; Wallin K; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
    Hum Immunol; 2001 Oct; 62(10):1153-8. PubMed ID: 11600224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students.
    Mahmud SM; Robinson K; Richardson H; Tellier PP; Ferenczy AS; Roger M; Coutlee F; Franco EL
    J Infect Dis; 2007 Jul; 196(1):82-90. PubMed ID: 17538887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
    Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
    Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
    Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
    Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levels.
    Ramachandran D; Schürmann P; Mao Q; Wang Y; Bretschneider LM; Speith LM; Hülse F; Enßen J; Bousset K; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Tarbiat J; Runnebaum I; Dürst M; Hein A; Koch M; Ruebner M; Ekici A; Beckmann MW; Fasching PA; Luyten A; Petry KU; Hillemanns P; Dörk T
    Int J Cancer; 2020 Nov; 147(9):2458-2468. PubMed ID: 32580243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
    Chen D; Gyllensten U
    Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study of susceptibility loci for cervical cancer.
    Chen D; Juko-Pecirep I; Hammer J; Ivansson E; Enroth S; Gustavsson I; Feuk L; Magnusson PK; McKay JD; Wilander E; Gyllensten U
    J Natl Cancer Inst; 2013 May; 105(9):624-33. PubMed ID: 23482656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.
    Gokhale P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Salvi V; Mania-Pramanik J
    Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S36-43. PubMed ID: 25673541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix.
    Sastre-Garau X; Loste MN; Vincent-Salomon A; Favre M; Mouret E; de la Rochefordiere A; Durand JC; Tartour E; Lepage V; Charron D
    Int J Cancer; 1996 Jun; 69(3):159-64. PubMed ID: 8682580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese.
    Chan PK; Cheung TH; Lin CK; Siu SS; Yim SF; Lo KW; Cheung JL; Tam AO; Tang JW
    J Med Virol; 2007 Jul; 79(7):970-6. PubMed ID: 17516530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
    Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S
    Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host and viral genetics and risk of cervical cancer: a review.
    Hildesheim A; Wang SS
    Virus Res; 2002 Nov; 89(2):229-40. PubMed ID: 12445662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women.
    Cervantes J; Lema C; Valentina Hurtado L; Andrade R; Hurtado Gomez L; Torrico L; Zegarra L; Quiroga G; Asturizaga D; Dulon A; Prada R; Panoso W; Yashiki S; Fujiyoshi T; Sonoda S
    Hum Immunol; 2003 Sep; 64(9):890-5. PubMed ID: 12941545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.
    Thakur N; Hussain S; Kohaar I; Tabassum R; Nasare V; Tiwari P; Batra S; Bhambhani S; Das BC; Basir SF; Bharadwaj D; Bharadwaj M
    Biomarkers; 2009 Jun; 14(4):219-25. PubMed ID: 19489683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphisms in the DNA repair genes in HPV-positive cervical cancer.
    Bajpai D; Banerjee A; Pathak S; Thakur B; Jain SK; Singh N
    Eur J Cancer Prev; 2016 May; 25(3):224-31. PubMed ID: 25812040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.